4Filing Date: Sep 10, 2026
Bristol Myers (BMY)
Statement of Changes in Beneficial Ownership
View SEC Filing
ACC: 0002080176-26-000006
Total Value$403.5K
Trades1
Insiders1
Transaction Details
Massacesi Cristian
EVP,Chief Med Offr,Head of Dev·Direct
Sell · Dispose
Common Stock, $0.10 par value
Shares-6.25K
Price$64.57
Total Value$403.5K
Shares Owned After18.75K
Transaction DateSep 9, 2026
Post-Transaction Holdings
Massacesi Cristian · EVP,Chief Med Offr,Head of Dev
| Security | Shares | Change |
|---|---|---|
| Common Stock, $0.10 par value | 18.75K | -6.25K (-25.00%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-09-09
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: BRISTOL MYERS SQUIBB CO (BMY)
CIK: 0000014272
--- Reporting Owner ---
Name: Massacesi Cristian
CIK: 0002080176
Role: Officer (EVP,Chief Med Offr,Head of Dev)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock, $0.10 par value
Date: 2026-09-09 | Code: S (Open market sale)
Shares: -6,249 | Price: $64.57
Total Value: $403,497.93
Shares Owned After: 18,748 | Ownership: D (Direct)
--- Signature ---
/s/ /s/ Amy Fallone, attorney-in-fact for Cristian Massacesi (2026-09-10)